EA004049B1
(ru)
*
|
1998-11-10 |
2003-12-25 |
Янссен Фармацевтика Н.В. |
Пиримидины, ингибирующие репликацию вич
|
GB9914258D0
(en)
*
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
WO2001022938A1
(fr)
*
|
1999-09-24 |
2001-04-05 |
Janssen Pharmaceutica N.V. |
Compositions antivirales
|
DE19945982A1
(de)
*
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
WO2001025220A1
(fr)
|
1999-10-07 |
2001-04-12 |
Amgen Inc. |
Inhibiteurs de triazine kinase
|
WO2001060816A1
(fr)
|
2000-02-17 |
2001-08-23 |
Amgen Inc. |
Inhibiteurs de kinases
|
EP1282606B1
(fr)
|
2000-05-08 |
2015-04-22 |
Janssen Pharmaceutica NV |
Inhibiteurs de la replication du vih
|
CA2407754C
(fr)
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Promedicaments a base de pyrimidines inhibant la replication du vih
|
WO2002056132A2
(fr)
*
|
2000-11-01 |
2002-07-18 |
Snapnames Com Inc |
Systeme et procede d'acquisition et de gestion de noms de domaine
|
US6958211B2
(en)
|
2001-08-08 |
2005-10-25 |
Tibotech Bvba |
Methods of assessing HIV integrase inhibitor therapy
|
US8101629B2
(en)
|
2001-08-13 |
2012-01-24 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
|
US7638522B2
(en)
|
2001-08-13 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
|
JO3429B1
(ar)
*
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
EP1453516A2
(fr)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Nouvelles pyrimidines substituees, procede permettant de les produire et leur utilisation comme medicament
|
CA2463989C
(fr)
|
2001-10-17 |
2012-01-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Derives pyrimidine, compositions pharmaceutiques contenant ces composes, utilisation et procede de fabrication de ces composes
|
BR0213792A
(pt)
|
2001-11-01 |
2004-12-07 |
Janssen Pharmaceutica Nv |
Heteroaril aminas como inibidores de glicogênio sintase cinase 3beta (inibidores de gsk3)
|
ATE375331T1
(de)
|
2001-11-01 |
2007-10-15 |
Janssen Pharmaceutica Nv |
Amidderivate als inhibitoren der glycogensynthasekinase-3-beta
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
US7767679B2
(en)
|
2002-03-13 |
2010-08-03 |
Janssen Pharmaceutica N.V. |
Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
|
ES2371632T3
(es)
|
2002-03-13 |
2012-01-05 |
Janssen Pharmaceutica N.V. |
Nuevos inhibidores de desacetilasa de histona.
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
EA008244B1
(ru)
*
|
2002-05-03 |
2007-04-27 |
Янссен Фармацевтика Н.В. |
Полимерные микроэмульсии
|
AR039540A1
(es)
*
|
2002-05-13 |
2005-02-23 |
Tibotec Pharm Ltd |
Compuestos microbicidas con contenido de pirimidina o triazina
|
AR040456A1
(es)
|
2002-06-27 |
2005-04-06 |
Bristol Myers Squibb Co |
Piridina n-oxidos 2,4 -disubstituidos utiles como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana
|
PL216744B1
(pl)
|
2002-07-29 |
2014-05-30 |
Rigel Pharmaceuticals |
Zastosowanie związku 2,4-diaminopirymidyny do wytwarzania leku do leczenia lub do zapobiegania chorobom autoimmunizacyjnym
|
CA2493794C
(fr)
|
2002-08-09 |
2010-05-25 |
Janssen Pharmaceutica N.V. |
Procedes de preparation de 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
|
CN1703200B
(zh)
*
|
2002-09-20 |
2012-02-29 |
奥尔制药公司 |
隔离亚单元和相关组合物及方法
|
RS20050363A
(en)
*
|
2002-11-28 |
2007-11-15 |
Schering Aktiengesellschaft, |
Chk-,pdk-and akt-inhibitory pyrimidines,their production an use as pharmaceutical agents
|
EA011009B1
(ru)
|
2003-01-14 |
2008-12-30 |
Арена Фармасьютикалз Инк. |
1,2,3-тризамещённые арильные и гетероарильные производные в качестве модуляторов метаболизма и профилактика и лечение расстройств, связанных с ним, таких как диабет и гипергликемия
|
CN102503903A
(zh)
*
|
2003-02-07 |
2012-06-20 |
詹森药业有限公司 |
抑制hiv的1,2,4-三嗪
|
US20070021449A1
(en)
|
2003-02-07 |
2007-01-25 |
Jan Heeres |
Pyrimidine derivatives for the prevention of hiv infection
|
DE602004021472D1
(en)
*
|
2003-02-20 |
2009-07-23 |
Smithkline Beecham Corp |
Pyrimiidinverbindungen
|
CL2004000303A1
(es)
*
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
CN1822843B
(zh)
*
|
2003-07-17 |
2010-04-28 |
泰博特克药品有限公司 |
制备含有抗病毒药物颗粒的方法
|
WO2005012294A1
(fr)
|
2003-07-30 |
2005-02-10 |
Rigel Pharmaceuticals, Inc. |
Composes 2,4-pyrimidinediamine a utiliser dans le traitement ou la prevention de maladies auto-immunes
|
CN100475815C
(zh)
*
|
2003-09-25 |
2009-04-08 |
詹森药业有限公司 |
抑制hiv复制的嘌呤衍生物
|
US8099262B2
(en)
|
2004-03-02 |
2012-01-17 |
Virco Bvba |
Estimation of clinical cut-offs
|
EP1598343A1
(fr)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
Dérivés de 2-arylaminopyrimidines comme des inhibiteurs de PLK
|
WO2006010750A1
(fr)
|
2004-07-28 |
2006-02-02 |
Janssen Pharmaceutica N.V. |
Derives d'indolyl alkyl amine substitues utilises en tant que nouveaux inhibiteurs d'histone deacetylase
|
CN101035773B
(zh)
|
2004-08-10 |
2012-06-06 |
詹森药业有限公司 |
抑制hiv的1,2,4-三嗪-6-酮衍生物
|
CA2573976C
(fr)
*
|
2004-09-30 |
2014-04-29 |
Tibotec Pharmaceuticals Ltd. |
5-carbo- ou heterocycliques pyrimidines substituees inhibitrices de vih
|
RU2405778C2
(ru)
|
2004-09-30 |
2010-12-10 |
Тиботек Фармасьютикалз Лтд. |
5-гетероциклилпиримидины, ингибирующие вич
|
BRPI0516748B8
(pt)
*
|
2004-09-30 |
2021-05-25 |
Janssen Sciences Ireland Uc |
pirimidinas 5-substituídas inibidoras de hiv e composição farmacêutica que as compreende
|
JP5118972B2
(ja)
|
2004-10-29 |
2013-01-16 |
テイボテク・フアーマシユーチカルズ |
Hiv阻害性二環式ピリミジン誘導体
|
JP2008519073A
(ja)
*
|
2004-11-08 |
2008-06-05 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
チプラナビル及びエトラビリンの同時投与によるhiv感染症の治療法
|
US7557207B2
(en)
|
2004-11-24 |
2009-07-07 |
Rigel Pharmaceuticals, Inc. |
Spiro 2,4-pyrimidinediamine compounds and their uses
|
ES2337496T3
(es)
|
2005-01-19 |
2010-04-26 |
Rigel Pharmaceuticals, Inc. |
Profarmacos de compuestos de 2,4-pirimidindiamina y sus usos.
|
ATE523498T1
(de)
*
|
2005-01-27 |
2011-09-15 |
Tibotec Pharm Ltd |
Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
|
DK1853588T3
(da)
|
2005-02-16 |
2008-09-15 |
Astrazeneca Ab |
Kemiske forbindelser
|
ES2533258T3
(es)
*
|
2005-02-18 |
2015-04-08 |
Janssen Sciences Ireland Uc |
Derivados de óxido de 2-(4-cianofenilamino)pirimidina que inhiben el VIH
|
BRPI0609291B1
(pt)
|
2005-03-04 |
2022-02-08 |
Janssen Sciences Ireland Uc |
2-(4-ciano-fenil)-o-hidroxilamina-pirimidinas que inibem hiv, composição farmacêutica que as compreende e processo para a preparação de ambas
|
CA2608009A1
(fr)
|
2005-05-16 |
2006-11-23 |
Astrazeneca Ab |
Composes chimiques
|
DK1888537T3
(da)
|
2005-05-26 |
2013-12-09 |
Janssen R & D Ireland |
Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril
|
MX286273B
(es)
|
2005-06-08 |
2011-05-04 |
Rigel Pharmaceuticals Inc |
Composiciones y metodos para inhibicion de la via jak.
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
US7754773B2
(en)
*
|
2005-10-06 |
2010-07-13 |
University Of Massachusetts |
Composition and synthesis of new reagents for inhibition of HIV replication
|
ES2391783T3
(es)
|
2005-10-28 |
2012-11-29 |
Astrazeneca Ab |
Derivados de 4-(3-aminopirazol)pirimidina para su uso como agentes inhibidores de las tirosina cinasas en el tratamiento del cáncer
|
EP1981874B1
(fr)
|
2006-01-19 |
2009-05-27 |
Janssen Pharmaceutica, N.V. |
Dérivés d'aminophényle en tant que nouveaux inibiteurs d'histone désacétylase
|
EP1981875B1
(fr)
|
2006-01-19 |
2014-04-16 |
Janssen Pharmaceutica N.V. |
Dérivés substitués d'indolyl-alkyl-amine en tant qu'inhibiteurs de l'histone désacétylase
|
CN101370790B
(zh)
|
2006-01-19 |
2015-10-21 |
詹森药业有限公司 |
作为组蛋白去乙酰化酶抑制剂的吡啶和嘧啶衍生物
|
US8962643B2
(en)
|
2006-02-24 |
2015-02-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
MX2008012577A
(es)
|
2006-03-30 |
2008-10-10 |
Tibotec Pharm Ltd |
Pirimidinas sustituidas con 5-(hidroximetileno y aminometileno) que inhiben el virus de inmunodeficiencia humana.
|
AU2007233737B2
(en)
*
|
2006-03-30 |
2012-11-29 |
Janssen Sciences Ireland Uc |
HIV inhibiting 5-amido substituted pyrimidines
|
AR060890A1
(es)
|
2006-05-15 |
2008-07-23 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina y composicion farmaceutica en base a ellos
|
DK2029110T3
(da)
|
2006-06-06 |
2011-12-19 |
Tibotec Pharm Ltd |
Fremgangsmåde til fremstilling af sprøjtetørrede formuleringer med TMC125
|
MX2008016372A
(es)
|
2006-06-19 |
2009-05-28 |
Alpharma Inc |
Composiciones farmaceuticas.
|
CA2665726C
(fr)
*
|
2006-10-11 |
2016-04-19 |
Alpharma, Inc. |
Compositions pharmaceutiques
|
EP2104491B1
(fr)
|
2006-12-06 |
2017-02-22 |
Janssen Sciences Ireland UC |
Sel d'hydrobromide d'un composé anti-vih
|
BRPI0720858B8
(pt)
*
|
2006-12-29 |
2021-05-25 |
Janssen R & D Ireland |
pirimidinas 6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
|
US8318736B2
(en)
|
2006-12-29 |
2012-11-27 |
Janssen R&D Ireland |
HIV inhibiting 5,6-substituted pyrimidines
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
WO2009051782A1
(fr)
*
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Étravirine deutérée
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
WO2009079521A1
(fr)
*
|
2007-12-17 |
2009-06-25 |
Alpharma Pharmaceuticals, Llc |
Composition pharmaceutique
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
EA029131B1
(ru)
|
2008-05-21 |
2018-02-28 |
Ариад Фармасьютикалз, Инк. |
Фосфорсодержащие производные в качестве ингибиторов киназы
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
TWI458721B
(zh)
|
2008-06-27 |
2014-11-01 |
Celgene Avilomics Res Inc |
雜芳基化合物及其用途
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
UY32158A
(es)
*
|
2008-10-03 |
2010-04-30 |
Astrazeneca Ab |
Derivados heterociclicos y metodos de uso de los mismos
|
US20110071158A1
(en)
*
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
US8754093B2
(en)
|
2009-03-30 |
2014-06-17 |
Janssen R&D Ireland |
Co-crystal of etravirine and nicotinamide
|
CA2760794C
(fr)
|
2009-05-05 |
2017-07-25 |
Dana Farber Cancer Institute |
Inhibiteurs d'egfr et procedes de traitement de troubles
|
WO2010131118A2
(fr)
*
|
2009-05-12 |
2010-11-18 |
Pliva Hrvatska D.O.O. |
Formes polymorphes d'étravirine et leurs procédés de préparation
|
AP2858A
(en)
|
2009-06-22 |
2014-02-28 |
Emcure Pharmaceuticals Ltd |
Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
|
WO2011017079A1
(fr)
|
2009-07-27 |
2011-02-10 |
Teva Pharmaceutical Industries Ltd. |
Procédé de préparation et de purification d'etravirine et intermédiaires de celui-ci
|
GR1007010B
(el)
|
2009-10-08 |
2010-10-07 |
Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), |
Ινσουλινοειδη πεπτιδια
|
SI2576541T1
(sl)
|
2010-06-04 |
2016-07-29 |
F. Hoffmann-La Roche Ag |
Aminopirimidinski derivati kot modulatorji lrrk2
|
CA2803848A1
(fr)
|
2010-06-28 |
2012-01-05 |
Hetero Research Foundation |
Procede de preparation d'intermediaire de l'etravirine et de polymorphes de l'etravirine
|
US8563568B2
(en)
|
2010-08-10 |
2013-10-22 |
Celgene Avilomics Research, Inc. |
Besylate salt of a BTK inhibitor
|
BR112013008100A2
(pt)
|
2010-09-22 |
2016-08-09 |
Arena Pharm Inc |
"moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
|
WO2012061303A1
(fr)
|
2010-11-01 |
2012-05-10 |
Avila Therapeutics, Inc. |
Composés hétéroaryle et leurs utilisations
|
WO2012061299A1
(fr)
|
2010-11-01 |
2012-05-10 |
Avila Therapeutics, Inc. |
Composés hétérocycliques et leurs utilisations
|
LT3124483T
(lt)
|
2010-11-10 |
2019-09-25 |
Genentech, Inc. |
Pirazolo aminopirimidino dariniai, kaip lrrk2 moduliatoriai
|
US8796255B2
(en)
|
2010-11-10 |
2014-08-05 |
Celgene Avilomics Research, Inc |
Mutant-selective EGFR inhibitors and uses thereof
|
ES2655525T3
(es)
|
2011-04-26 |
2018-02-20 |
Mylan Laboratories Ltd. |
Proceso novedoso para la preparación de Etravirina
|
BR112013027734A2
(pt)
|
2011-05-04 |
2017-08-08 |
Ariad Pharma Inc |
compostos para a inibição de proliferação celular em cânceres impulsionados pelo egfr, método e composição farmacêutica
|
WO2012170647A1
(fr)
*
|
2011-06-09 |
2012-12-13 |
Assia Chemical Industriew Ltd. |
Procédé pour la préparation d'étravirine et intermédiaires dans la synthèse de celle-ci
|
JP5993010B2
(ja)
|
2011-08-23 |
2016-09-14 |
エンドゥ ファーマシューティカルズ,インコーポレイティド |
ピリミド−ピリダジノン化合物及びその使用
|
WO2013059572A1
(fr)
|
2011-10-19 |
2013-04-25 |
Assia Chemical Industries Ltd. |
Procédé de préparation d'etravarine et produits intermédiaires utiles dans la synthèse de ce composé
|
EP2770830A4
(fr)
|
2011-10-28 |
2015-05-27 |
Celgene Avilomics Res Inc |
Méthodes de traitement d'une maladie ou d'une affection associée à la tyrosine-kinase btk (bruton's tyrosine kinase)
|
US8703786B2
(en)
*
|
2011-12-07 |
2014-04-22 |
Texas Southern University |
Etravirine formulations and uses thereof
|
PT2825042T
(pt)
|
2012-03-15 |
2018-11-16 |
Celgene Car Llc |
Sais de um inibidor de cinases do recetor do fator de crescimento epidérmico
|
EP2825041B1
(fr)
|
2012-03-15 |
2021-04-21 |
Celgene CAR LLC |
Formes solides d'un inhibiteur de kinases du récepteur du facteur de croissance épidermique
|
AU2013204563B2
(en)
|
2012-05-05 |
2016-05-19 |
Takeda Pharmaceutical Company Limited |
Compounds for inhibiting cell proliferation in EGFR-driven cancers
|
WO2014068588A2
(fr)
*
|
2012-10-29 |
2014-05-08 |
Biophore India Pharmaceuticals Pvt. Ltd. |
Procédé de synthèse d'étravirine et ses intermédiaires
|
WO2014072419A1
(fr)
|
2012-11-08 |
2014-05-15 |
Universiteit Antwerpen |
Nouveaux composés anti-vih
|
EP2934501A4
(fr)
|
2012-12-21 |
2016-06-01 |
Verlyx Pharma Inc |
Utilisations et méthodes concernant le traitement de maladies ou d'affections hépatiques
|
WO2014100748A1
(fr)
|
2012-12-21 |
2014-06-26 |
Celgene Avilomics Research, Inc. |
Composés hétéroarylés et leurs utilisations
|
ES2805359T3
(es)
|
2013-02-08 |
2021-02-11 |
Celgene Car Llc |
Inhibidores de ERK y sus usos
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
US10005760B2
(en)
|
2014-08-13 |
2018-06-26 |
Celgene Car Llc |
Forms and compositions of an ERK inhibitor
|
US11007175B2
(en)
|
2015-01-06 |
2021-05-18 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
CN104926829A
(zh)
*
|
2015-06-08 |
2015-09-23 |
山东大学 |
一种噻吩并嘧啶类衍生物及其制备方法和应用
|
EP3939965A1
(fr)
|
2015-06-22 |
2022-01-19 |
Arena Pharmaceuticals, Inc. |
Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique pour une utilisation dans des troubles associés au récepteur de s1p1
|
CN110066273A
(zh)
*
|
2019-06-05 |
2019-07-30 |
山东大学 |
一种含三氮唑环的单芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用
|
CA3145864A1
(fr)
|
2019-07-03 |
2021-01-07 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Inhibiteurs de tyrosine kinase non recepteur 1 (tnk1) et leurs utilisations
|
CN111217833B
(zh)
*
|
2020-02-21 |
2021-03-16 |
山东大学 |
噻吩并[2,3-d]嘧啶类HIV-1非核苷类逆转录酶抑制剂及其制备方法和应用
|
CN111875548A
(zh)
*
|
2020-07-16 |
2020-11-03 |
山东大学 |
一种5位芳环取代的二芳基嘧啶类衍生物及其制备方法与应用
|